《复牌公告》先施(00244.HK)控股股东宣称送赠契据无效
先施(00244.HK)公布,本月3日,收到控股股东Win Dynamic信函,宣布於去年10月底签订的送赠契据属无效且即时取消,原因是该契据是在受到不当影响及威迫并且在概无获给予独立法律代表或适当意见之情况下签立,而根据香港法例,该契据属於一项逊值交易。
先施董事会正在考虑该信函之含意,且不承认该契据属无效或已被取消,亦不承认信函中所提述之任何其他事宜。
声明提醒,该契据之存在与否并非要约之先决条件之一,而董事会认为Win Dynamic据称取消该契据不会对要约人即将作出之要约造成影响。
公司股份申请周五(5日)恢复买卖。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.